Core Viewpoint - Picard Medical, Inc. has announced its initial public offering (IPO) pricing, aiming to raise $17 million through the sale of 4,250,000 shares at a price of $4.00 per share [1] Fund Utilization - The company plans to use the proceeds from the IPO primarily for market expansion through its joint venture in China, SynCardia Medical (Beijing), Inc. [1] - Funds will also be allocated for research and development, including next-generation products and new technologies, such as portable drive systems [1] - Additional uses of the funds include enhancing sales, marketing, and distribution capabilities, increasing inventory and drive system base, repaying debt, and supplementing working capital for general corporate purposes [1]